ACTRN12617001316392已完成未知
A phase 1 pre-post intervention trial with 12 week baseline control determining the merits of a lower limb robotic exoskeleton (HELLEN) in the rehabilitation of Multiple Sclerosis (MS).
niversity of Newcastle0 个研究点目标入组 10 人开始时间: 2017年9月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Diagnosis of MS
- •2. Resident of the Hunter region over the age of 18 years
- •3. Severe mobility impairment whereby the participant is reliant on a mobility aid or other people for upright activities (Scores >6 on the Expanded Disability Status Scale)
排除标准
- •1. Weight >100kg or <40kg; height >6'4 or <4'8 (criteria set by the REX Bionics)
- •2. Pregnancy
- •3. Unstable or severe cardiac or respiratory conditions
- •4. Recent fractures in lower limbs/pelvis/spine
- •5. Significant cognitive impairment (<19 on MoCA)
- •6. Any medical condition which limits the ability to exercise in an upright position
研究者
相似试验
已完成
不适用
Can Enhanced Recovery After Surgery (ERAS) principles be implemented in an Australian healthcare setting to improve patient recovery after total hip replacement (THR)?total hip replacementtotal hip arthroplastyanaesthesiarecovery after anaesthesiaperioperative medicinepostoperative analgesiaAnaesthesiology - AnaestheticsAnaesthesiology - Pain managementMusculoskeletal - OsteoarthritisACTRN12615001170516icole Tan230
已完成
不适用
Prevention of type 2 diabetes mellitus through educational intervention for adolescents at risk in high schools in JordaOverweight or obese adolescents at high risk for type 2 diabetes mellitusNutritional, Metabolic, EndocrineDiabetes mellitusISRCTN38144270Al -Zaytoonah University (Jordan)400
招募中
4 期
A clinical trial to evaluate aflibercept treatment in patients with diabetic macular edema.CTRI/2022/08/044792Bayer Zydus Pharma Private Limited
进行中（未招募）
1 期
A 12-month prospective, randomized, interventional, global, multi-center, active-controlled study comparing sustained benefit of two treatment paradigms in adult episodic migraine patientsMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersMigraine preventionEUCTR2018-001228-20-DEovartis Pharma AG600
进行中（未招募）
1 期
A 12-month prospective, randomized, interventional, global, multi-center, active-controlled study comparing sustained benefit of two treatment paradigms in adult episodic migraine patientsMigraine preventionMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersEUCTR2018-001228-20-PTovartis Pharma AG621